ClinicalTrials.Veeva

Menu

Tele-rehabilitation Through CIMT at Recovering the Function of the Upper Limb and Quality of Life (TeleCIMT)

U

Universidad de La Frontera

Status

Completed

Conditions

Telerehabilitation

Treatments

Procedure: TeleCIMT

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The current pandemic scenario is immensely challenging for healthcare professionals. Telerehabilitation,is a promising option that benefited many people, allowing continuity of therapeutic processes and promoting the admission of people without prior access to rehabilitation programs. This modality has shown comparable results with conventional rehabilitation strategies, applied in patients with neurological pathologies. However, the modalities applied and the quality of the studies are insufficient to establish their real benefits and effectiveness.

Strategies such as CIMT, have been shown to be effective in improving upper limb function and restoring quality of life in stroke survivors. However, there is little evidence on its effectiveness when administered under telerehabilitation modality.

Full description

Objective To determine if movement-induced restriction therapy, delivered through telerehabilitation (TeleCIMT), recovers function and improves quality of life in patients with brachial sequelae, after a stroke.

Methodology A prospective, single-group experimental study will be conducted. The sample will be of an intentional type, selected according to meeting the inclusion criteria. Each participant will be evaluated three times, at the beginning, middle and end of the intervention using TeleCIMT. The evaluation scales to be used will be Motor Activity Log-30 (MAL-30) and Action Research Arm for function and ECVI-38 scale for quality of life. The difference between these measurements in each patient (change score) will express the progress (or setback) obtained through this modality of intervention via telerehabilitation. Specifically, the effects of the TeleCIMT will be examined by one-factor within-subject analysis of variance (ANOVA) using time (T1, T2, and T3) as the independent variable and the recovery measures as dependent variables. In all analyzes, results with p values less than or equal to 0.05 will be considered statistically significant.

Expected results Through this proposal, the aim is to promote a line of research that allows the development of scientific evidence in the area of telerehabilitation in subjects with neurological pathologies. This information will benefit numerous professionals, promoting timely access to rehabilitation, providing continuity in therapeutic processes and reversing levels of disability due to neurological pathologies.

Enrollment

22 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged between 30 and 80 years.
  • Who present a single stroke event confirmed by CT,
  • Between 5 and 14 points on the NIHSS Scale
  • Who have the ability to sit independently.
  • Who can follow simple instructions (score greater than 13 on the Mini Menta)l.
  • <2 points on the Modified Ashworth Scale on elbow and wrist
  • <4 points on the Visual Analog Scale on shoulder.
  • That they can perform a functional test of 20 ° of wrist extension and 10 ° of finger extension (take and drop a cloth with the affected hand).

Exclusion criteria

  • Severe cognitive impairment (aphasia, attention deficit, reasoning or memory disorders).
  • Severe sensory impairment (visual-auditory).
  • Orthopedic limitation (use of a cane).

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

22 participants in 1 patient group

TeleCIMT group
Experimental group
Description:
One month after baseline evaluations, patients will receive a 3-week program through TeleCIMT. * Task Oriented Repetitive Training * Use of the Affected Upper Extremity * Transfer Package
Treatment:
Procedure: TeleCIMT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems